Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Alcon has reported global sales of $1,536.4 million for the first quarter of 2008, an increase of 16.2% compared to the first quarter of 2007, or 9.4% excluding the impact of foreign exchange fluctuations.
Subscribe to our email newsletter
Net earnings for the first quarter of 2008 increased 24% to $429.4 million, or $1.43 per share on a diluted basis, compared to $346.2 million, or $1.14 per share for the first quarter of 2007.
International sales rose 25.6% to $864.4 million, or 12.6% excluding exchange, with emerging markets sales increasing 28.6%, or 17.6% excluding exchange. Gross profit margin improved 0.5 percentage points to 74.1% of sales.
Pharmaceutical sales grew 13.3%, or 7.8% on a constant currency basis, to $628.4 million. Surgical sales rose 20.2% or 12% to $697.9 million. And Consumer eye care sales increased 12.1%, or 6.2% to $210.1 million.
Cary Rayment, Alcon’s chairman, president and CEO, said: “Our strong results for the first quarter came from continuing market share gains for our major pharmaceutical brands, our strong performance in Japan with several new pharmaceutical products, rapid growth in sales of our advanced technology intraocular lenses, and the continuing contributions of our international operations, especially those in emerging markets.”